PHYSIOLOGICAL MARKERS FOR ANXIETY DISORDER--PD AND GAD
焦虑症的生理标志——PD 和 GAD
基本信息
- 批准号:2675530
- 负责人:
- 金额:$ 22.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-05-15 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): The DSM-IV classification
of anxiety disorders postulates a number of distinct diseases presumed to
have different biological underpinnings. Although physiological symptoms
such as rapid heart beat and breathlessness are important component criteria
for both Panic Disorder (PD) with and without agoraphobia, and Generalized
Anxiety Disorder (GAD), diagnosis is based on subjective report of
physiological disturbance rather than its objective measurement. The
clinical phenomenology of PD and GAD suggests different temporal patterns,
e.g., abrupt surges of activation in panic attacks versus more sustained
activation in phobic situations and in GAD. While primarily characterized
by sustained activation, GAD patients may also show short spikes of
activation associated with intrusive, worried thoughts. Biologic mechanisms
proposed to account for the phenomenology of PD, with and without
agoraphobia, include autonomic instability, hyperventilation, suffocation
false alarm, and epileptic discharge. Ambulatory monitoring and laboratory
tests (relaxation, habituation, breath holding, hyperventilation,
concomitants of thought, and classical conditioning) developed specifically
to assess these physiological mechanisms will be used in two separate
studies. Study 1 will compare 30 GAD patients, 30 PD patients with
agoraphobia, and 30 controls. Study 2 will compare 20 PD patients with
agoraphobia, 20 PD patients without agoraphobia, and 20 controls. In Study
2, ambulatory monitoring will include a behavioral avoidance test in a
shopping mall. Analysis will determine if:
1. PD patients manifest more spontaneous autonomic fluctuations coinciding
with dips and/or peaks in end-tidal pCO2 and electroencephalography changes
suggesting epileptic discharge, than controls and GAD patients.
2. PD patients respond with more exaggerated psychophysiological reactions
to dips and peaks in end-tidal pCO2 produced respiratory maneuvers than GAD
patients or controls.
3. GAD patients and PD patients with agoraphobia habituate more slowly to
noise bursts than PD patients without agoraphobia or controls.
4. Emotional conditioning to noise bursts is acquired more quickly and is
more resistant to extinction in PD patients with agoraphobia than PD
patients without agoraphobia or controls.
5. Physiological activation is related to subjective report of anxiety and
panic and specific anxiety symptoms.
描述(改编自申请人摘要):DSM-IV分类
焦虑症的诊断假设了许多不同的疾病,
有不同的生物学基础。 虽然生理症状
例如快速心跳和呼吸困难是重要组成标准
对于伴有和不伴有广场恐怖症的惊恐障碍(PD),
焦虑症(GAD),诊断是基于主观报告,
生理干扰,而不是其客观测量。 的
PD和GAD的临床现象学提示不同的时间模式,
例如,在一个实施例中,惊恐发作时的突然激活,
在恐惧症和广泛性焦虑症中的激活。 虽然主要特点是
通过持续的激活,GAD患者也可能表现出短暂的
与侵入性的、忧虑的想法有关的激活。 生物学机制
提出解释PD的现象学,有和没有
广场恐怖症,包括自主神经不稳定,换气过度,窒息
虚惊一场癫痫放电 动态监测和实验室
测试(放松,习惯,屏气,过度换气,
思想的伴随物,和经典条件作用)
为了评估这些生理机制,将在两个独立的
问题研究 研究1将比较30名GAD患者、30名PD患者和30名
广场恐怖症和30名对照。 研究2将比较20例PD患者,
广场恐怖症,20例PD患者无广场恐怖症,20名对照。 在自习
2、门诊监测将包括行为回避测试,
商场 分析将确定是否:
1. PD患者表现出更多的自发性自主神经波动,
潮气末pCO 2下降和/或达到峰值以及脑电图变化
提示癫痫样放电。
2. PD患者的心理生理反应更为夸张
对潮气末pCO 2的下降和峰值产生的呼吸动作比GAD
患者或对照组。
3. GAD患者和患有广场恐怖症的PD患者更慢地适应
噪声爆发比PD患者没有广场恐怖症或控制。
4. 对噪音爆发的情绪调节更快地获得,
PD广场恐怖症患者比PD更难消退
无广场恐怖症的患者或对照组。
5. 生理激活与焦虑的主观报告有关,
恐慌和特定的焦虑症状。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WALTON Thompson ROTH其他文献
WALTON Thompson ROTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WALTON Thompson ROTH', 18)}}的其他基金
PTSD Hyperarousal Symptoms Treated with Physiological Stress Management
通过生理压力管理治疗 PTSD 过度警觉症状
- 批准号:
7685552 - 财政年份:2009
- 资助金额:
$ 22.69万 - 项目类别:
PTSD Hyperarousal Symptoms Treated with Physiological Stress Management
通过生理压力管理治疗 PTSD 过度警觉症状
- 批准号:
8195989 - 财政年份:2009
- 资助金额:
$ 22.69万 - 项目类别:
PTSD Hyperarousal Symptoms Treated with Physiological Stress Management
通过生理压力管理治疗 PTSD 过度警觉症状
- 批准号:
7790555 - 财政年份:2009
- 资助金额:
$ 22.69万 - 项目类别:
Respiratory Therapeutic Procedures in Panic Disorder
恐慌症的呼吸治疗程序
- 批准号:
6924716 - 财政年份:2004
- 资助金额:
$ 22.69万 - 项目类别:
Respiratory Therapeutic Procedures in Panic Disorder
恐慌症的呼吸治疗程序
- 批准号:
6825619 - 财政年份:2004
- 资助金额:
$ 22.69万 - 项目类别:
Respiratory Therapeutic Procedures in Panic Disorder
恐慌症的呼吸治疗程序
- 批准号:
7095176 - 财政年份:2004
- 资助金额:
$ 22.69万 - 项目类别:
PHYSIOLOGICAL MARKERS FOR ANXIETY DISORDER--PD AND GAD
焦虑症的生理标志——PD 和 GAD
- 批准号:
2034915 - 财政年份:1997
- 资助金额:
$ 22.69万 - 项目类别:
PHYSIOLOGICAL MARKERS FOR ANXIETY DISORDER--PD AND GAD
焦虑症的生理标志——PD 和 GAD
- 批准号:
2890839 - 财政年份:1997
- 资助金额:
$ 22.69万 - 项目类别:
相似海外基金
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
- 批准号:
10109165 - 财政年份:2024
- 资助金额:
$ 22.69万 - 项目类别:
Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
- 批准号:
10677075 - 财政年份:2023
- 资助金额:
$ 22.69万 - 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
- 批准号:
478121 - 财政年份:2023
- 资助金额:
$ 22.69万 - 项目类别:
Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
- 批准号:
10861961 - 财政年份:2023
- 资助金额:
$ 22.69万 - 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
- 批准号:
22KJ3164 - 财政年份:2023
- 资助金额:
$ 22.69万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
- 批准号:
10685283 - 财政年份:2022
- 资助金额:
$ 22.69万 - 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
- 批准号:
10042996 - 财政年份:2022
- 资助金额:
$ 22.69万 - 项目类别:
Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10705005 - 财政年份:2022
- 资助金额:
$ 22.69万 - 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
- 批准号:
10597521 - 财政年份:2022
- 资助金额:
$ 22.69万 - 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
- 批准号:
10573948 - 财政年份:2022
- 资助金额:
$ 22.69万 - 项目类别:














{{item.name}}会员




